Trial site
Thomas Jefferson University, Sidney Kimmel Cancer Center
- 14running trials
- 9closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Lung cancer11 trials
- Colorectal cancer6 trials
- Ovarian cancer6 trials
- Head and neck cancer5 trials
- Prostate cancer5 trials
- Bladder cancer4 trials
- Pancreatic cancer4 trials
- Endometrial cancer3 trials
- Gastric and oesophageal cancer3 trials
- Sarcoma3 trials
- Acute lymphoblastic leukaemia2 trials
- Acute myeloid leukaemia2 trials
- and 13 more
- Phase
- Phase 110 trials
- Phase 1/29 trials
- Phase 22 trials
- Phase 32 trials
- Status
- Recruiting8 trials
- Active, not recruiting5 trials
- Completed5 trials
- Terminated4 trials
- Not yet recruiting1 trial
- Lead sponsor
- Prelude Therapeutics Incorporated3 trials
- Clasp Therapeutics, Inc.2 trials
- Amgen1 trial
- BicycleTx Limited1 trial
- BlossomHill Therapeutics1 trial
- and 15 more
Running trials
Not yet recruiting
A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer5 recruiting
- Colorectal cancer4 recruiting
- Bladder cancer3 recruiting
- Head and neck cancer3 recruiting
- Gastric and oesophageal cancer2 recruiting
- Ovarian cancer2 recruiting
- Pancreatic cancer2 recruiting
- Endometrial cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Completed
Terminated
Completed
A Study of PRT2527 in Participants With Advanced Solid Tumors
Terminated
Terminated
A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma
Terminated
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
Completed
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026